CAR T-Matters (PT2030 Consortium)

About Stemmatters

Stemmatters is a private, revenue-generating CDMO based in Guimarães, Portugal, offering end-to-end contract development and cGMP manufacturing solutions for regenerative medicine products. It operates as a one-stop shop, providing services in contract development, analytical testing, formulation development, and manufacturing for cell therapies, including iPSC-derived products and CAR-T cells. The company is actively engaged in collaborative R&D projects and partnerships, positioning itself as a key European player in the advanced therapy CDMO landscape.